Eolus Vind AB (publ) (EOLU-B)
Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 46.50 |
|---|---|
| 52-week range | 33.25 – 53.50 |
| Return, 1 month / 3 months | −8.1% / +26.4% |
| Return, 1 year / 3 years | +14.7% / −35.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 44.8% |
| Worst drawdown (1 year) | -24.0% |
| Average daily value traded | 2.10M SEK |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eolus Vind is a Swedish company that develops wind power projects. It identifies suitable sites, secures permits, and oversees the construction of wind farms, which it then sells to investors and utilities. The company also provides management and operational services for wind farms owned by others. Its customers include energy companies, institutional investors and other owners of renewable power assets, and it is based in Hässleholm, Sweden.
On this site Eolus Vind AB (publ) appears as a stock on the Stockholm Exchange (Sweden), code EOLU-B, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eolus Vind AB (publ) (EOLU-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 46.50 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 143 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.7% and over the last three months it rose 26.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.5% | ||
| From 52-week high | -10.7% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 26.4% | ||
| 6-month return | 18.2% | ||
| 12-month return, skipping the last month | 24.8% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.0% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.10M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | −8.1% |
| 3 months | +26.4% |
| 6 months | +18.2% |
| 1 year | +14.7% |
| 3 years | −35.4% |
| 5 years | −67.5% |
Signals
| 50-day / 200-day average | 47.71 / 41.34 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Nov 2025 | SEK 1.5000 |
| 16 May 2025 | SEK 0.7500 |
| 17 May 2024 | SEK 2.2500 |
| 15 May 2023 | SEK 1.5000 |
| 20 May 2022 | SEK 1.5000 |
| 20 May 2021 | SEK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.